Bridgeway Capital Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,444
Closed -$27K 1304
2025
Q4
$27K Hold
12,444
﹤0.01% 1205
2025
Q3
$68.6K Buy
12,444
+644
+5% +$4.92K ﹤0.01% 1144
2025
Q2
$88.5K Hold
11,800
﹤0.01% 1092
2025
Q1
$77.4K Hold
11,800
﹤0.01% 1081
2024
Q4
$155K Hold
11,800
﹤0.01% 1052
2024
Q3
$67K Buy
+11,800
New +$78.4K ﹤0.01% 1197
2024
Q1
Sell
-7,500
Closed -$82.5K 1363
2023
Q4
$82.5K Hold
7,500
﹤0.01% 1269
2023
Q3
$133K Buy
+7,500
New +$273K ﹤0.01% 1171

Other funds holding RBOT

Bridgeway Capital Management's RBOT Position: Q1 2026 in Review

Bridgeway Capital Management sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 12,444 shares — an estimated $27K sold.

Bridgeway Capital Management first reported a position in RBOT in Q3 2023 and held it in 8 quarters. The position peaked at $155K in Q4 2024. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Bridgeway Capital Management reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,444 Vicarious Surgical shares in Q1 2026, an estimated $27K.
  • Bridgeway Capital Management first reported a position in Vicarious Surgical in Q3 2023 and held it in 8 quarters.
  • Bridgeway Capital Management's Vicarious Surgical position peaked at $155K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.